this post was submitted on 02 Dec 2025
1 points (100.0% liked)

China News

93 readers
13 users here now

A community for china news

founded 3 months ago
MODERATORS
 

Chinese drug maker 3SBio plans to raise HK$3.12 billion (US$401 million) by selling a 4.14 per cent stake in the company to fund clinical research in China and the US and expand the global reach of its drug portfolio. The Shenyang-based biopharmaceutical firm has agreed to sell 105.1 million new shares at HK$29.62 each. The placing price represents a 6.5 per cent discount compared with Monday’s closing price of HK$31.68, according to its filing with the Hong Kong stock exchange on Tuesday. The...


From China - South China Morning Post via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here